Fort Lee, New Jersey, Aug. 21, 2014 (GLOBE NEWSWIRE) -- Herborium® Group, Inc. (OTC Pink: HBRM), www.Herborium.com, a Botanical Therapeutics® Company and the provider of unique all botanical medicinal products (Botanical Therapeutics®) that target dermatological problems such as acne, and other health and wellness concerns in the areas of sexual performance as well as energy depletion and stress, has successfully deployed a responsive design e-commerce infrastructure and joined $300 billion plus mobile market.
During first two months of new system operation Herborium mobile sales grew 25%. Since Herborium sales for the first seven months of 2014 has surpassed the sales realized in the entire year of 2013this rapid growth reaffirms the present run rate for AcnEase® sales for 2014 to exceed $1 million.
The mobile sales is growing rapidly worldwide and online retail sales in the USA will grow from $225.5 billion in 2012 to $434.2 billion in 2017, according to eMarketer Forrester Research and the web will account for 11% of U.S. retail sales in 2018.
In addition, Herborium's novel all botanical acne treatment - AcnEase® continues its rapid growth in French market and the Company hired a French marketing and sales representative to monetize the growing interest in a product by both e- commerce and traditional channels.
Herborium remains very optimistic about growing its business, sales and product awareness driven by the steady growth of the AcnEase® brand as well as advanced preparation to commercialize its new products: Lasting Pleasure® and Lasting Power® later this year.
The Company continues its efforts to decrease costs and to retire debt, thus increasing the Company's ability to secure outside funding with reasonable commercial terms.
There is rising interest in Botanical Therapeutics® among consumers as well as the financial and medical communities that will serve as a solid foundation for the company's promising future.
About Herborium Group, Inc.Herborium Group, Inc., a botanical therapeutics® company that develops, license and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, women's health and selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, diabetes, surgical procedures, and other problems. Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce. For more information, please visit www.herborium.com, and www.acnease.com.
Safe Harbor Statement: This release contains forward-looking statements with respect to the results of operations and business of Sunrise Consulting Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.
Herborium Group, Inc.